chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Psoriasis getting worse; Pain during injection; Primary series was Pfizer and booster dose was Moderna; Primary series was Pfizer and booster dose was Moderna; After Moderna vaccine, patient ran a fever; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Psoriasis getting worse), COVID-19 IMMUNISATION (Primary series was Pfizer and booster dose was Moderna), INTERCHANGE OF VACCINE PRODUCTS (Primary series was Pfizer and booster dose was Moderna), PYREXIA (After Moderna vaccine, patient ran a fever) and INJECTION SITE PAIN (Pain during injection) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Plaque psoriasis: HUMIRA from 02-Jul-2019 to 24-Apr-2020 and HUMIRA from 02-Jul-2019 to 24-Apr-2020. Past adverse reactions to the above products included Drug effect incomplete with HUMIRA; and Pain during injection with HUMIRA. Concomitant products included TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced PYREXIA (After Moderna vaccine, patient ran a fever). On 30-Nov-2021, the patient experienced COVID-19 IMMUNISATION (Primary series was Pfizer and booster dose was Moderna) and INTERCHANGE OF VACCINE PRODUCTS (Primary series was Pfizer and booster dose was Moderna). On an unknown date, the patient experienced PSORIASIS (Psoriasis getting worse) and INJECTION SITE PAIN (Pain during injection). In 2021, PYREXIA (After Moderna vaccine, patient ran a fever) had resolved. At the time of the report, PSORIASIS (Psoriasis getting worse), COVID-19 IMMUNISATION (Primary series was Pfizer and booster dose was Moderna), INTERCHANGE OF VACCINE PRODUCTS (Primary series was Pfizer and booster dose was Moderna) and INJECTION SITE PAIN (Pain during injection) outcome was unknown.            Humira was administered subcutaneously and formulation reported was Solution for injection in pre-filled pen. The reporter's causality for drug effect incomplete, pyrexia was no reasonable possibility and for Pain during injection was reasonable possibility. No treatment information was reported. It was unknown if patient was enrolled in a COVID-19 vaccine trial. Reporter did not have the lot number information, because the packaging was discarded. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Patient requested Johnson and Johnson (Janssen) COVID-19 vaccine and pharmacist mistakenly administered Pfizer-BioNTech COVID-19 vaccine instead
Strange itchy rash at the injection site with pronounced raised pimples. A patch about 2" in diameter, redness, and inflamed. Arm was extremely sore for the first two days following the injection.
About 5 minutes after receiving vaccination, employee became diaphoretic, lightheaded and developed Right Shoulder Pain along with Palpitations.  Employee went to ER department where she was monitored further. States  symptoms continued for over an hour after receiving vaccination.
62-year-old male with number of medical problems that include history of hepatitis-C, history of cirrhosis, history of alcohol abuse, cocaine abuse, history of diabetes hypertension who has initially presented to EMS with increasing shortness of breath.  Patient suffered cardiac arrest during his transportation to the emergency room.  A CPR was initiated and was given 3 rounds of epinephrine.  Most of the history is taken from the ER physician chart review.   ACUTE RESPIRATORY FAILURE SECONDARY TO HYPOXEMIA, COVID-19 , cardiac arrest, possible anoxic brain damage  : Patient is 62-year-old male with complicated history with history of hepatitis-C, cirrhosis, alcohol use, cocaine abuse diabetes who presented after having cardiac arrest and possible anoxic brain damage.  Patient was intubated after the arrest.  Patient stayed in the hospital for number of days.  Patient was found to have COVID-19 positive.  Patient was found to have diffuse bilateral infiltrate.  Patient was started on broad-spectrum antibiotics including cefepime Flagyl and Decadron.  Due to patient's cardiac arrest patient was started on hypothermia protocol.  Patient was rewarming after that.  There was no purposeful movement or neurological recovery.  After long discussion with the family, patient has been made comfort care.  Patient was extubated.  Patient expired promptly after that.  Family is notified.
Patient stated 3 days after receiving vaccine, she had nausea, vomiting and became dehydrated. She had to be admitted to the hospital overnight to receive fluids. She stated she did not change her diet. She had been drinking fluids. She does not believe symptoms were due to any food she'd eaten or food poisoning. Patient stayed overnight in the hospital. Hospital location unknown.
Extreme swelling, pain, redness & hardness of arm injected lasting for 3 days. Swelling, redness, hardness eventually dissipated. Pain spread to upper shoulder, armpit and neck. Still experiencing pain 3 weeks later which limits arm movement despite pain killers & allergy meds.
swelling of arm; itchy; red patch around vaccination site; warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling of arm), PRURITUS (itchy), VACCINATION SITE REACTION (red patch around vaccination site) and VACCINATION SITE WARMTH (warm to touch) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling of arm), PRURITUS (itchy), VACCINATION SITE REACTION (red patch around vaccination site) and VACCINATION SITE WARMTH (warm to touch). At the time of the report, PERIPHERAL SWELLING (swelling of arm), PRURITUS (itchy), VACCINATION SITE REACTION (red patch around vaccination site) and VACCINATION SITE WARMTH (warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Pt recvd 1 dose of Engerix-B & exp severe diarrhea on 2JUL92 which lasted 6 days; treated w/anti diarrheal agents;
Fast heart rate, Swelling in lymph nodes in neck (went away after 24 hours); Lichenplanus reaction (oral and vaginal).  Given oral and vaginal steriods.
Two days after injection developed rash starting at injection site then spreading over arms, neck, chest, abdomen, and thighs.
Enlarged, sore lymph node right mid clavicle. 0.8mm; sore lymph node right mid clavicle. 0.8mm; This is Spontaneous report from a contactable Nurse (patient).  A 61-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Lot EL1238, intramuscular in arm right on 09Jan2021 13:00 at single dose for covid-19 immunisation.  The patient previously received the first dose of BNT162B2 on 19Dec2020 at 10:00 AM,  lot number: EH9899, Intramuscular in arm left for covid-19 immunisation. The patient did not receive other vaccine in four weeks. The patient medical history was not reported.  The patient did not have covid prior vaccination, and she was not tested for covid post vaccination. There were not known allergies. Concomitant medication included acetylsalicylic acid (ASPIRIN), and colecalciferol (VITAMIN D).  The patient experienced enlarged, sore lymph node right mid clavicle. 0.8mm on 11Jan2021 18:00. The patient did not receive treatment. The outcome was not recovered.
Swollen armpit lymphnodes around 11am, followed by body chills and muscle aches. Fatigue happened around 3. After Tylenol chills went away after 7 hours but my armpits still hurt 24 hours later.
I started to experience nausea, diarrhea and just the feeling of being unwell. I shared that information with the physician in the ER, she automatically stated that I had COVID-19. I received the anti-body infusion the same day as my visit. I was very surprised that I tested positive after being fully vaccinated plus I received all three booster shots.
I received vaccine doses on 2/16/21 and second on 3/16/21.  Trying to complete good deeds for Lent, I donated Plasma for the first and only time on 3/7/21.  On 3/8/21 my right calf starting seizing up and I was experiencing calf pain.  I was advised to do stretches and use a heating pad. It persisted for over a week and I went for a Doppler ultrasound scan on 3/17/21.  Blood clots were found.  The Plasma donation center screening led me to believe that they were concerned with other vaccines but not the Covid19 vaccine.  Writing report because I  think there is a possible connection to the blood clots, vaccine and plasma donation.  I had to "do nothing" for three weeks and have been placed on Eliquis, a blood thinner for four months.  Follow-up with Dr. for blood work and Doppler in July.
Pt called c/o (R) arm pain, unable to lift arm over head or put arms straight down. Pt states no swelling or black & blue mark. Spoke with pt on 12/9/11. Pt advised to alternate MOTRIN & TYLENOL & ice arm and call on-call doctor if symptoms worsen at weekend.
Pain, swelling and baseball sized lump at injection site-told to expect pain & redness by pharmacist. Abrupt onset of chills, fever which began approximately 28 hours after 1st dose of SHINGRIX. Lasted from approximately 5:30pm (day after initial dose) until 1:00am culminating in a break in fever and complete drenching of body in "cold sweat". Intense headache then began and continued until 6:00am. After that, all symptoms resolved with the exception of the pain, redness and swelling at the injection site; area has become more diffuse but continues to be red and very tender.
Arm is still hurting; Could not sleep; Felt very tired and awful; Sick and stayed in bed for a day and a half; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm is still hurting), INSOMNIA (Could not sleep), FATIGUE (Felt very tired and awful) and VACCINATION COMPLICATION (Sick and stayed in bed for a day and a half) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm is still hurting), INSOMNIA (Could not sleep), FATIGUE (Felt very tired and awful) and VACCINATION COMPLICATION (Sick and stayed in bed for a day and a half). At the time of the report, VACCINATION SITE PAIN (Arm is still hurting), INSOMNIA (Could not sleep), FATIGUE (Felt very tired and awful) and VACCINATION COMPLICATION (Sick and stayed in bed for a day and a half) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient had bad swelling and rash from PREVNAR site (right upper arm) for almost seven days and watery diarrhea for four days. After eight days patient reported the adverse effects to the pharmacist with no longer aforementioned adverse events.
Information has been received from a health care professional concerning a 41 month old male pt who on 8/14/97 was vaccinated with the varicella vaccine in the left arm. On 1/12/00 the pt developed herpes zoster on the left arm and on his radial nerve distribution. The pt had a somewhat vesicular rash over the fingers, the thumb, index and little finger and on the dorsum of the hand. The pt also had a couple of patches on the arm that are in the same nerve distribution. Additionally it was noted that the pt developed a left eye infection. The pt sought unspecified medical treatment and was admitted to a hospital. On an unspecified date the pt recovered.
9:55 AM after vaccines patient became dizzy- pale color, skin moist. 9:58 AM Ammonium Inhalants 1/1 administered intranasal- and wet, cool, paper towel applied to face and forehead. 10:02 AM B/P 110/60-70-18. 10:15 AM Patient stated he felt better. Instructed if he has any other problems take to M.D. 10:30 AM Patient denies pain and no noted blisters left other ambulatory.
Patient reported arm soreness following his initial injection on 4/29/2021.  The soreness then went away and returned on 5/15/2021.  He says his arm hurts to touch as well as hurts with movement.  Patient says these are the same symptoms as he had after the initial shot and to the same degree of pain.  No redness or raised area.  Patient is taking a narcotic for previous backpain that does not relieve his discomfort.  I told him to followup with his doctor.
This case was considered medically important (OMIC). Information regarding Prevnar was received from a mother regarding her 3 year old son who experienced developmental delay, described as speech, social and behavioral delay, zinc deficiency, a build up of lead, mercury and various other toxic metals. The pt received the fourth dose on 4/3/02. The mother reported that her son experienced "developmental difficulties, and a build up of lead, mercury, and various other toxic metals, and a zinc deficiency." The developmental difficulties were described as "speech, social, and behavioral delay with no apparent motor skill delay and no diagnosis of autism, at least not yet." The mother stated that the onset of events was undetermined, "although he didn't seem right as a baby." The initial diagnosis of developmental delay was given about one and a half years ago. The heavy metal build up and zinc deficiency was determined by blood and hair testing, done in the fall of 2003. Since fall, 2003, her son has been receiving "help from a developmental specialist." He "is doing much better, and progressing." The mother reported that a physician "is correcting the chemical imbalance and detoxifying his system with vitamins and minerals including zinc." No additional info was available at the time of this report.
Member became cool, clammy and pale and pupils dilated almost immediately after immunization was administered. The patient was sitting down in a chair so he did not suffer any trauma. Did not lose consciousness but did seem as if he was not oriented to time and place. Physician was called into the room and immediately after EMS arrived on scene.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was provided regarding the patient's past medical history, concurrent conditions, or concomitant medications. The patient was inoculated with ZOSTAVAX (lot number, dosage, and route of administration not provided) on or about 26-SEP-2011 at a clinic, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of shingles. On or about 23-AUG-2013, the patient was treated by a physician for the onset of a blistery rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. The patient experienced symptoms so severe and persistent, she was forced to retire early from her employment due to her condition. As a direct and proximate result of these malfunctions, the patient has suffered and will continue to suffer significant medical expenses, lost wages, pain and suffering, and other damages. Herpes zoster/shingles and weakened immune symptoms were considered to be disabling. Additional information has been requested.
METALLIC TASTE; HOARSE; CLEAR THROAT; CHILLS; MOUTH TINGLING; FEVER 103 DEGREES; SWOLLEN TONGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 19-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 19-AUG-2021, the patient experienced swollen tongue. On an unspecified date, the patient experienced metallic taste, hoarse, clear throat, chills, mouth tingling, and fever 103 degrees. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride, and famotidine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swollen tongue on 20-AUG-2021, and the outcome of metallic taste, hoarse, clear throat, mouth tingling, fever 103 degrees and chills was not reported. This report was non-serious.
severe vomiting episodes; severe stomach cramping and pains; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (severe vomiting episodes) and ABDOMINAL PAIN UPPER (severe stomach cramping and pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced VOMITING (severe vomiting episodes) and ABDOMINAL PAIN UPPER (severe stomach cramping and pains). On 01-Mar-2021, VOMITING (severe vomiting episodes) and ABDOMINAL PAIN UPPER (severe stomach cramping and pains) had resolved.            No concomitant medication reported  No treatment information was provided    Reporter did not allow further contact
extreme nausea  lasting 5 days  went to E R on Sunday Am    was prescribed anti nausea medication  was followed up by doctor on  Monday AM  prescribed stronger anti nausea medicine
pt recv vax 9JUN97 & 23SEP97 pt exp varicella outbreak & was seen by MD who dx approx 30 lesions;there was no fever noted;
Patient stated right arm where vaccine was sore for a week then pain started to travel around neck and into left arm. Felt sort of paralysis.
Change to menstrual cycle (from 5-7 days heavy flow to 1 day of light flow and 2-3 days spotting). Still continuing 6 months later.
Vaccine 1: warts/welts developed immediately following and continuing outer upper joint left  middle finger, after than same location on right middle finger, next left index finger outer upper joint , then mirrored on right joint. Now I have a little on on outer pinkie finger-right hand-not sore like the others. Left middle finger is still sore. hand ortho. X-rays  it and said it was spontaneous arthritis that happened dot occur after shot. 48 hours after second shot- middle of night- I felt back of legs feel inflamed and swollen. Difficulty walking for 2 days- then left leg cleared dup and rights leg ongoing for a while. It recurred  with the exact pattern two Sundays ago. u knee orthopedist says it is not his area. he is referring me to a rheumatologist. I wish there was a COVID clinic for complications. I would also like to consult with an immunologist. My sciatic nerve on right has been inflamed.
pt devel diffuse arthralgias & classic erythema multiforme a wk p/vax;no prior such illness;responded promptly to pred, tapered from 60mg over 12 days;
Intractable migraine for 4 days, required 2 MD visits.  Fever and chills the first 24 hours. joint aches
pt recv vax & devel dermatitis characterized by burning, itching & transitory redness over both eyes;pt recently discovered allergic to thimerosal;pt attributed dermatitis to allergic rxn to thimerosal;
No adverse event reported. This was an administration error.  Administered Moderna vaccine to a 17 year old when it is approved for 18 years and older.    Pharmacist thought all Covid vaccinations were approved for 16 years and up.
About 30 minutes after vaccination the client experienced numbness and tingling on the entire left side of his body lasting for a couple hours. It included the left side face, neck, arm and lower extremity. Client did have PCR diagnosed COVID 10/29/20. The symptoms resolved spontaneously with no residual effect.
Had pox on chest and hands, tightness in chest, shortness of breath, rapid heart beat & diarrhea
Swollen left eye. Eye was red, tearing, scratchy and hurt to blink. Patient may have rubbed nose then rubbed eye. Upon eye swelling adminstered cold compress and nose started to run. Severe swelling started to reduce in about two hours but swelling was still present in the morning when she went to school.
Flu vaccine at 11:30 am woke from nap at 2:30 pm with hives over torso and buttocks. Hives improved with BENARDYL.
Red itchy patch around the injection site; Red itchy patch around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Red itchy patch around the injection site) and VACCINATION SITE ERYTHEMA (Red itchy patch around the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L70A) for COVID-19 vaccination.     Concomitant products included ACYCLOVIR [ACICLOVIR] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red itchy patch around the injection site). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Red itchy patch around the injection site). At the time of the report, VACCINATION SITE PRURITUS (Red itchy patch around the injection site) and VACCINATION SITE ERYTHEMA (Red itchy patch around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.